Primary Site >> Liver Cancer

Gene >> CCL20

  • 2002
  • 2003
  • 2006
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. International Agency for Research on Cancer.
PMID: 12358081
Ref: Liver metastasis of cancer facilitated by chemokine receptor CCR6.
PMID: 12791091
Ref: Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma.
PMID: 16764701
Ref: Hepatitis C virus core protein induces expression of genes regulating immune evasion and anti-apoptosis in hepatocytes.
PMID: 16876223
Ref: Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
PMID: 17075975
Ref: The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer.
PMID: 19480006
Ref: Chemokines and hepatocellular carcinoma.
PMID: 20397259
Ref: Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases.
PMID: 21912453
Ref: Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
PMID: 21935436
Ref: Tissue-specific transplantation antigen P35B (TSTA3) immune response-mediated metabolism coupling cell cycle to postreplication repair network in no-tumor hepatitis/cirrhotic tissues (HBV or HCV infection) by biocomputation.
PMID: 22528125
Ref: High therapeutic concentration of prazosin up-regulates angiogenic IL6 and CCL2 genes in hepatocellular carcinoma cells.
PMID: 23089469
Ref: Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes.
PMID: 23150092
Ref: The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
PMID: 24743888
Ref: The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma.
PMID: 25698534
Ref: [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].
PMID: 25877311
Ref: Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators.
PMID: 26273651
Ref: Global analysis of DNA methylation in hepatocellular carcinoma by a liquid hybridization capture-based bisulfite sequencing approach.
PMID: 26300991
Ref: HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma.
PMID: 26653219
Ref: CCL20-CCR6 Cytokine Network Facilitate Treg Activity in Advanced Grades and Metastatic Variants of Hepatocellular Carcinoma.
PMID: 26331965
Ref: Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis.
PMID: 26837767
Ref: A tumour-promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways.
PMID: 27797409
Ref: CCR6(+) B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesis.
PMID: 28560063
Ref: Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.
PMID: 28674001
Ref: HCV-induced EGFR-ERK signaling promotes a pro-inflammatory and pro-angiogenic signature contributing to liver cancer pathogenesis.
PMID: 30012461
Ref: Recruitment and significance of Th22 cells and Th17 cells in malignant ascites.
PMID: 30250609
Ref: CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
PMID: 30287142